Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A systematic literat... by N. A. Avxentyev, I. I. Andreyashkina, E. V. Artamonova, L. V. Bolotina, E. I. Kovalenko, N. N. Sisigina

Subjects: Get full text

Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer by Navid Sobhani, Alberto D’Angelo, Matteo Pittacolo, Giandomenico Roviello, Anna Miccoli, Silvia Paola Corona, Ottavia Bernocchi, Daniele Generali, Tobias Otto

Subjects: Get full text

Cyclin-dependent kinase inhibitors: efficacy and safety by I. B. Kononenko, A. V. Snegovoi, V. Yu. Selchuk

Subjects: Get full text

Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Revie... by Ye M, Xu H, Ding J, Jiang L

Subjects: Get full text

Recent Advances in the Treatment of Breast Cancer by Christy W. S. Tong, Mingxia Wu, William C. S. Cho, Kenneth K. W. To

Subjects: Get full text